ThomasShimshakMD

PubMed

• Left Atrial Masses: Now You See Them, Now You Don't.
  Windross, D., Brands, C., Krishnan, G., Punjani, S., Shimshak, T.> ;Cureus. 2023 Dec 1
• Successful Treatment of Recurrent Pericarditis With Rilonacept in Acute Promyelocytic Leukemia.
  Majid, M., Yaker, Z., Agrawal, A., Arockiam, A., Kafil, T., Brands, C., Atar, M., Gerds, A., Shimshak, T., Klein, A.> ;JACC. Case Reports. 2023 Nov 1
• 4 citations
  Infrainguinal lesion-specific device choices: round-table discussion.
  Tony Das, Jean Paul Beregi, Lawrence A. Garcia, Omran Abul-Khoudoud, John R. Laird, Alan B. Lumsden, Sean P. Lyden, Mark W. Mewissen, Thomas M. Shimshak> ;Journal of Endovascular Therapy. 2006 Feb 1
• 15 citations
  Contemporary endovascular treatment for disease of the superficial femoral and popliteal arteries: an integrated device-based strategy.
  Sean P. Lyden, Thomas M. Shimshak> ;Journal of Endovascular Therapy. 2006 Feb 1
• 11 citations
  Usefulness of optical coherent reflectometry with guided radiofrequency energy to treat chronic total occlusions in peripheral arteries (the GRIP trial).
  Romas J. Kirvaitis, Richard R. Heuser, Tony Das, Steven B. Laster, Eric J. Dippel, Roger S. Gammon, Charles F. Botti, Bruce E. Murphy, Thomas A. Biggs, Thomas A. Shims...> ;The American Journal of Cardiology. 2004 Oct 15
• 5 citations
  Successful exclusion of a left main coronary artery aneurysm with a PTFE-covered coronary stent.
  John J Young, Andrew D Schreiner, Thomas M. Shimshak, Dean J. Kereiakes> ;The Journal of Invasive Cardiology. 2004 Aug 1
• Durable clinical benefit following Sr90 Beta irradiation therapy for in-stent restenosis in high-volume community practice.
  John J Young, Daniel P. Marcus, Charles W. Abbottsmith, Thomas M. Broderick, Joseph K. Choo, John Paul Runyon, John F. Schneider, Thomas M. Shimshak, Rodney P. Geier, ...> ;The Journal of Invasive Cardiology. 2003 Jan 1
• 2 citations
  Extensive thrombus prior to elective percutaneous coronary intervention.
  David E. Kandzari, Victor S. Behar, Michael H. Sketch, Dean J. Kereiakes, Thomas M. Shimshak, Thomas M. Broderick, John J Young, John Paul Runyon, Robert D. Safian, Mo...> ;The Journal of Invasive Cardiology. 2001 Jul 1
• Ticlopidine monotherapy following coronary stent deployment: "penny wise and pound foolish".
  Dean J. Kereiakes, John J Young, John Paul Runyon, Thomas M. Shimshak> ;The Journal of Invasive Cardiology. 2001 Jun 1
• 86 citations
  Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management
  Eric J. Dippel, Dean J. Kereiakes, Daniel A. Tramuta, Thomas M. Broderick, Thomas M. Shimshak, Eli M. Roth, Charles R. Hattemer, John Paul Runyon, David D. Whang, John...> ;Catheterization and Cardiovascular Interventions. 2001 Mar 1
• 63 citations
  Dalteparin in combination with abciximab during percutaneous coronary intervention
  Dean J. Kereiakes, Neal S. Kleiman, Edward T.A. Fry, Grace Mwawasi, Rose Lengerich, Kelly Maresh, Mary Lynn Burkert, Joseph W. Aquilina, Michael DeLoof, Thomas M. Brod...> ;American Heart Journal. 2001 Mar 1
• 6 citations
  Therapeutic adjuncts for immediate transfer to the catheterization laboratory in patients with acute coronary syndromes.
  Dean J. Kereiakes, John J Young, Thomas M. Broderick, Thomas M. Shimshak, Charles W. Abbottsmith> ;The American Journal of Cardiology. 2000 Dec 28
• 22 citations
  Abciximab provides cost-effective survival advantage in high-volume interventional practice.
  Dean J. Kereiakes, Robert L. Obenchain, Beth L. Barber, Andrew L. Smith, Mark McDonald, Thomas M. Broderick, John Paul Runyon, Thomas M. Shimshak, John F. Schneider, C...> ;American Heart Journal. 2000 Oct 1
• 33 citations
  IIb's are not IIb's.
  Dean J. Kereiakes, John Paul Runyon, Thomas M. Broderick, Thomas M. Shimshak> ;The American Journal of Cardiology. 2000 Apr 27
• 9 citations
  Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromes.
  Dean J. Kereiakes, Mark McDonald, Thomas M. Broderick, Eli M. Roth, David D. Whang, Linda H. Martin, Wendy L. Howard, John F. Schneider, Thomas M. Shimshak, Charles W....> ;American Heart Journal. 2000 Feb 1
• 35 citations
  Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".
  Dean J. Kereiakes, Edward T.A. Fry, William H. Matthai, Niederman A, L Barr, Bruce R. Brodie, James P. Zidar, Paul N. Casale, Christy G, David J. Moliterno, Lengerich ...> ;The Journal of Invasive Cardiology. 2000 Feb 1
• Bleeding risks and vascular complications following abciximab therapy for percutaneous coronary intervention: a new look at an old problem.
  Dean J. Kereiakes, Thomas M. Broderick, Charles W. Abbottsmith, Thomas M. Shimshak> ;The Journal of Invasive Cardiology. 2000 Feb 1
• 3 citations
  Combination enoxaparin-abciximab therapy during coronary intervention: the next standard of care?
  Tramuta Da, Dean J. Kereiakes, Eric J. Dippel, Lengerich R, Thomas M. Broderick, Charles W. Abbottsmith, D.D. Whang, Eli M. Roth, John F. Schneider, Wendy L. Howard, T...> ;The Journal of Invasive Cardiology. 2000 Jan 1
• 109 citations
  Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneo...
  Dean J. Kereiakes, Thomas M. Broderick, Eli M. Roth, David D. Whang, Thomas A. Shimshak, John Paul Runyon, Charles R. Hattemer, John F. Schneider, Pam Lacock, Michele ...> ;The American Journal of Cardiology. 1999 Aug 15
• 160 citations
  Contemporary Percutaneous Treatment of Unprotected Left Main Coronary Stenoses Initial Results From a Multicenter Registry Analysis 1994–1996
  Stephen G. Ellis, Hideo Tamai, Masakiyo Nobuyoshi, Kunihiko Kosuga, Antonio Colombo, David R. Holmes, Carlos Macaya, Cindy L. Grines, Patrick L. Whitlow, Harvey J. Whi...> ;Circulation. 1997 Dec 2
• 51 citations
  Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery
  William J. Stephan, James H. O'Keefe, Jeffrey M. Piehler, Ben D. McCallister, Rajiv S. Dahiya, Thomas M. Shimshak, Robert W. Ligon, Geoffrey O. Hartzler> ;Journal of the American College of Cardiology. 1996 Nov 1
• 36 citations
  Results of direct percutaneous transluminal coronary angioplasty in octogenarians
  Steven B. Laster, Barry D. Rutherford, Lee V. Giorgi, Thomas M. Shimshak, David R. McConahay, Warren L. Johnson, Kenneth C. Huber, Robert W. Ligon, Geoffrey O. Hartzler> ;The American Journal of Cardiology. 1996 Jan 1
• 12 citations
  Directional atherectomy of left main stenoses
  Steven B. Laster, Barry D. Rutherford, David R. McConahay, Lee V. Giorgi, Warren L. Johnson, Thomas M. Shimshak, Kenneth C. Huber, Geoffrey O. Hartzler> ;Catheterization and Cardiovascular Diagnosis. 1994 Dec 1
• 28 citations
  Initial and long-term outcome of 83 patients after balloon angioplasty of totally occluded bypass grafts.
  Joel K. Kahn, Barry D. Rutherford, David R. McConahay, Warren L. Johnson, Lee V. Giorgi, Thomas M. Shimshak, Robert W. Ligon, Geoffrey O. Hartzler> ;Journal of the American College of Cardiology. 1994 Apr 1
• 38 citations
  Failed direct coronary angioplasty for acute myocardial infarction: In-hospital outcome and predictors of death
  John B. Bedotto, Joel K. Kahn, Barry D. Rutherford, David R. McConahay, Lee V. Giorgi, Warren L. Johnson, James H. O'Keefe, Thomas M. Shimshak, Robert W. Ligon, Geoffr...> ;Journal of the American College of Cardiology. 1993 Sep 1
• Join now to see all